Skip to main content

Table 1 Characteristics of RCC and control patients

From: Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma

Variable

RCC (n = 89)

Controls (n = 38)

Age Median (range)

62 (25-85)

57 (23-89)

Sex - no. (%)

  

   Male

52 (58.4)

20 (52.6)

   Female

37 (41.6)

18 (47.4)

Race - no. (%)

  

   Caucasian

66 (74.2)

28 (70.0)

   African American

9 (10.1)

6 (15.0)

   Hispanic

9 (10.1)

6 (15.0)

   East Indian

4 (4.5)

0

   Asian

1 (1.1)

0

Diagnosis - no. (%)

  

   RCC

89 (100)

 

   Stones

 

27 (71.1)

   Hematuria

 

9 (23.7)

   Renal Cyst

 

2 (5.3)

Approach - no. (%)

  

   Ablation

6 (6.7)

 

   Nephrectomy

83 (93.3)

 

         Open

42 (50.6)

 

         Laparoscopic

41 (49.4)

 

         Radical

36 (43.4)

 

         Partial

47 (56.6)

 

AJCC Stage† - no. (%)

  

   I

60 (73.2)

 

   II

7 (8.5)

 

   III

15 (18.3)

 

   IV

0

 

pT Classification† - no. (%)

  

   T1a

41 (49.4)

 

   T1b

20 (24.1)

 

   T2

7 (8.4)

 

   T3

1 (1.2)

 

   T3a

5 (6.0)

 

   T3b

9 (10.8)

 

   T3c

0

 

   T4

0

 

Pathologic Size† - median (range)

4.1 (1.3-25)

 

LN Involvement† - no. (%)

  

   NX

71 (85.5)

 

   N0

11 (13.3)

 

   N1

1 (1.2)

 

Histology - no. (%)

  

   Clear Cell

69 (77.5)

 

   Papillary

14 (15.7)

 

   Chromophobe

5 (5.6)

 

   Unclassified RCC

1 (1.1)

 

Fuhrman Grade† - no. (%)

  

   1

10 (12.0)

 

   2

44 (53.01)

 

   3

26 (31.33)

 

   4

3 (3.6)

 
  1. Analysis does not include patients treated with RFA.